-
Tata India Pharma & Healthcare Growth
Equity healthcare
Overview ( as on 27/10/25 )
NAV
₹30.84
Last change
₹-0.07 -0.0%
Fund Size (AUM)
1295.83 Cr
Performance
17.71% (5Y)
Fund Details
Tata India Pharma & Healthcare Growth
as of 27/10/25
AUM
1295.83 Cr
Expense Ratio
2.11 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Rajat Srivastava
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Growth | 2.1% | 21.93% | 17.71% |
| Nifty Pharma TR INR | -2.62% | 22.66% | 16.82% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
10.03% |
Apollo Hospitals Enterprise Ltd |
5.06% |
Lupin Ltd |
4.88% |
Cipla Ltd |
4.86% |
Torrent Pharmaceuticals Ltd |
4.68% |
HealthCare Global Enterprises Ltd |
4.68% |
Aster DM Healthcare Ltd Ordinary Shares |
4.63% |
Alkem Laboratories Ltd |
4.46% |
Max Healthcare Institute Ltd Ordinary Shares |
3.95% |
Divi's Laboratories Ltd |
3.86% |
Sector Allocation
Healthcare |
95.71% |
Basic Materials |
2.68% |
Financial |
1.61% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.45% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.77% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
19.83% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
19.83% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.67% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
17.67% (5Y)
-
